EurekAlert! -
31 Aug 2020 06:00
(Harry Perkins Institute of Medical Research) A major clinical trial involving 5,500 patients in Australia and the Netherlands found heart attacks and the need for coronary stenting or bypass surgery reduced by 30% in patients taking low dose colchicine, an old and widely available drug commonly used to treat gout.
Share this Article